$PPHM Avid Bioservices, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Avid Bioservices, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Avid Bioservices, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Avid Bioservices, Inc. Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
Bamforth Mark R | Director | 0 | 0 | Mar 19 2021 | |||
CARLEONE JOSEPH | Director | 66,945 | 21,422 | Dec 16 2020 | |||
Fussey Shelley PM | V.P., Intellectual Property | 135,908 | 43,491 | Nov 01 2016 | |||
Fussey Shelley PM | VP, Intellectual Property | 29,028 | 9,289 | Feb 03 2010 | |||
Fussey Shelley PM | V.P., Intellectual Property | 29,028 | 9,289 | Feb 11 2011 | |||
Fussey Shelley PM | V.P., Intellectual Property | 24,521 | 7,847 | Nov 02 2011 | |||
Fussey Shelley PM | V.P., Intellectual Property | 24,399 | 7,808 | May 03 2011 | |||
Fussey Shelley PM | V.P., Intellectual Property | 37,019 | 11,846 | May 01 2012 | |||
Green Nicholas Stewart | President & CEO | 0 | 0 | Jul 31 2020 | |||
Hancock Richard B | Director | 30,795 | 9,854 | May 07 2021 | |||
Hart Daniel Ryan | Chief Financial Officer | 19,737 | 6,316 | Jan 04 2021 | |||
JOHNSON CARLTON M | Director | 31,462 | 10,068 | Aug 29 2017 | |||
JOHNSON CARLTON M | Director | 0 | 0 | May 08 2014 | |||
JOHNSON CARLTON M | Director | 38,293 | 12,254 | Aug 31 2007 | |||
JOHNSON CARLTON M | Director | 0 | 0 | May 03 2011 | |||
JOHNSON CARLTON M | Director | 0 | 0 | Feb 21 2012 | |||
King F David | V.P. Business Development | 2,500 | 800 | Feb 16 2006 | |||
King F David | V.P., Business Development | 25,000 | 8,000 | Nov 20 2006 | |||
King F David | V.P., Business Development | 41,685 | 13,339 | Jan 11 2008 | |||
KING STEVEN W | President & CEO | 34,646 | 11,087 | Nov 01 2017 | |||
KING STEVEN W | President & CEO | 20,797 | 6,655 | Feb 16 2006 | |||
KING STEVEN W | President & CEO | 54,970 | 17,590 | Nov 20 2006 | |||
KING STEVEN W | President & CEO | 93,311 | 29,860 | Sep 24 2010 | |||
KING STEVEN W | President & CEO | 59,161 | 18,932 | Nov 02 2011 | |||
KING STEVEN W | President & CEO | 68,357 | 21,874 | May 03 2011 | |||
KING STEVEN W | President & CEO | 69,887 | 22,364 | May 01 2012 | |||
KING STEVEN W | President & CEO | 173,172 | 55,415 | Nov 04 2014 | |||
Lias Roger J. | President & CEO | 2,289 | 732 | Apr 30 2019 | |||
LYTLE PAUL J | Chief Financial Officer | 184,038 | 58,892 | Apr 28 2017 | |||
LYTLE PAUL J | Chief Financial Officer | 30,148 | 9,647 | Nov 20 2006 | |||
LYTLE PAUL J | Chief Financial Officer | 72,051 | 23,056 | Sep 27 2010 | |||
LYTLE PAUL J | Chief Financial Officer | 56,120 | 17,958 | Nov 02 2011 | |||
LYTLE PAUL J | Chief Financial Officer | 72,051 | 23,056 | Feb 11 2011 | |||
LYTLE PAUL J | Chief Financial Officer | 59,998 | 19,199 | May 03 2011 | |||
LYTLE PAUL J | Chief Financial Officer | 68,618 | 21,958 | May 01 2012 | |||
LYTLE PAUL J | Chief Financial Officer | 101,491 | 32,477 | May 08 2014 | |||
MACKEY CATHERINE J | Director | 0 | 0 | Dec 16 2020 | |||
Masten Jeffrey L. | V.P. Quality | 0 | 0 | Feb 21 2012 | |||
Masten Jeffrey L. | V.P. Quality | 12,498 | 3,999 | May 08 2012 | |||
Masten Jeffrey L. | V.P. Quality | 0 | 0 | May 08 2013 | |||
McComb Joel | Director | 24,267 | 7,765 | Dec 18 2018 | |||
POHL DAVID | Director | 0 | 0 | Aug 29 2017 | |||
POHL DAVID | Director | 0 | 0 | May 08 2014 | |||
POHL DAVID | Director | 0 | 0 | Feb 21 2012 | |||
POHL DAVID | Director | 0 | 0 | Mar 10 2005 | |||
POHL DAVID | Director | 0 | 0 | Feb 03 2010 | |||
SARGEN GREGORY | Director | 0 | 0 | Dec 16 2020 | |||
Shan Joseph | VP, Clinical and Reg Affairs | 16,187 | 5,180 | Nov 01 2017 | |||
Shan Joseph | VP Clinical/Regulatory Affairs | 25,436 | 8,140 | Feb 03 2010 | |||
Shan Joseph | VP, Clinical and Reg Affairs | 5,436 | 1,740 | Jul 05 2011 | |||
Shan Joseph | VP, Clinical/Regulatory Affair | 25,436 | 8,140 | Feb 11 2011 | |||
Shan Joseph | V.P. Clinical & Reg. Affairs | 15,436 | 4,940 | May 03 2011 | |||
Shan Joseph | V.P., Clinical & Reg. Affairs | 0 | 0 | Feb 21 2012 | |||
Shan Joseph | V.P., Clinical and Reg Affairs | 0 | 0 | May 08 2014 | |||
SWARTZ ERIC S | Director | 1,825,312 | 584,100 | Aug 29 2017 | |||
SWARTZ ERIC S | Director | 0 | 0 | Feb 21 2012 | |||
SWARTZ ERIC S | Director | 0 | 0 | May 08 2013 | |||
SWARTZ ERIC S | Director | 2,030,812 | 649,860 | Jun 13 2006 | |||
SWARTZ ERIC S | Director | 1,930,612 | 617,796 | Aug 01 2005 | |||
SWARTZ ERIC S | Director | 1,959,812 | 627,140 | Jan 27 2006 | |||
SWARTZ ERIC S | Director | 1,969,812 | 630,340 | Jan 30 2006 | |||
SWARTZ ERIC S | Director | 2,047,212 | 655,108 | Aug 28 2007 | |||
SWARTZ ERIC S | Director | 110,000 | 35,200 | Nov 09 2010 | |||
SWARTZ ERIC S | Director | 0 | 0 | Feb 03 2010 | |||
SWARTZ ERIC S | Director | 126,000 | 40,320 | May 08 2014 | |||
TAYLOR CLIVE R | Director | 19,000 | 6,080 | Mar 01 2004 | |||
Walsh Patrick D | Director | 30,000 | 9,600 | Dec 16 2020 | |||
Waltz Thomas A | Director | 0 | 0 | Mar 10 2005 | |||
Waltz Thomas A | Director | 2,500 | 800 | Dec 22 2006 | |||
Waltz Thomas A | Director | 0 | 0 | Jan 11 2008 | |||
Ziebell Mark R | V. P., General Counsel | 10,512 | 3,364 | Apr 14 2021 |